Visual dysfunction in migraine.
Foroozan
Rod
R
D004879:Ergotamines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D020325:Migraine with Aura / Q000150:complications; D015594:Optic Disk Drusen; D009901:Optic Nerve Diseases / Q000139:chemically induced; D018917:Optic Neuropathy, Ischemic / Q000209:etiology; D012164:Retinal Diseases / Q000175:diagnosis; D012307:Risk Factors; D020521:Stroke / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology* / Q000503:physiopathology; D015349:Vision, Monocular; D014794:Visual Fields; D014795:Visual Pathways / Q000503:physiopathology
D004879:Ergotamines